Cannabis and Citalopram (Celexa)
Brand names: Celexa
Important Medical Disclaimer
This information is for educational purposes only and does not constitute medical advice. Do not start, stop, or modify your use of Citalopram or cannabis without consulting your doctor or pharmacist. If you experience adverse effects, seek immediate medical attention. Individual responses to drug combinations vary significantly.
Overview
Citalopram is a selective serotonin reuptake inhibitor (SSRI) widely prescribed for depression and anxiety disorders. Its interaction with cannabis is rated moderate risk due to both pharmacokinetic concerns involving shared metabolic pathways and pharmacodynamic considerations related to mental health outcomes. Citalopram is metabolized primarily by CYP2C19 and CYP3A4, both of which can be inhibited by CBD. This could lead to increased citalopram levels and a higher risk of dose-dependent side effects, including the potentially dangerous cardiac effect of QT prolongation. Beyond the metabolic interaction, there are important clinical considerations for mental health. While some patients use cannabis to self-medicate anxiety or depression, research suggests that regular cannabis use — particularly heavy THC consumption — may worsen depression outcomes, interfere with antidepressant efficacy, and increase anxiety in the long term. The relationship between cannabis and mental health is complex, and patients on SSRIs should be aware that cannabis use could undermine their treatment goals even without a direct pharmacological interaction.
How They Interact
Citalopram is metabolized to its primary active metabolite desmethylcitalopram by CYP2C19, with CYP3A4 playing a significant secondary role. CBD inhibits both CYP2C19 and CYP3A4, which could increase citalopram plasma concentrations. Elevated citalopram levels are associated with dose-dependent QT prolongation — a cardiac conduction abnormality that can predispose to dangerous arrhythmias (torsades de pointes). The FDA has specifically warned that citalopram doses above 40 mg/day carry unacceptable QT prolongation risk, and anything that increases its blood levels effectively pushes patients toward this threshold. Pharmacodynamically, THC and serotonergic medications both influence mood and anxiety through interconnected neurotransmitter systems. The endocannabinoid system modulates serotonin release and receptor sensitivity, creating complex bidirectional interactions that can affect treatment response.
Cannabinoid-Specific Interactions
| Cannabinoid | Interaction with Citalopram |
|---|---|
| THC | THC can independently cause anxiety, particularly at higher doses, which may counteract citalopram's anxiolytic effects. Chronic heavy THC use has been associated with depressive symptoms and amotivation, potentially undermining antidepressant treatment. THC does not significantly inhibit the CYP enzymes involved in citalopram metabolism. |
| CBD | CBD inhibits both CYP2C19 and CYP3A4, the primary enzymes metabolizing citalopram. This can increase citalopram blood levels, raising the risk of side effects including QT prolongation, excessive sedation, nausea, and sexual dysfunction. The dose-dependent QT prolongation risk makes this pharmacokinetic interaction clinically significant. |
| CBN | CBN's sedative effects could add to the drowsiness commonly experienced with citalopram, particularly during the initial weeks of treatment. This combination may impair daytime functioning. |
Symptoms to Watch For
- ⚠Increased drowsiness or fatigue
- ⚠Worsening anxiety, particularly with high-THC cannabis
- ⚠Nausea, dizziness, or headache from elevated citalopram levels
- ⚠Heart palpitations or irregular heartbeat (possible QT prolongation)
Recommendations
- 1Inform your psychiatrist or prescriber about your cannabis use so they can account for potential interactions when dosing citalopram.
- 2If you use CBD regularly, your prescriber may want to check an EKG to monitor QT interval, especially if your citalopram dose is at the higher end of the range.
- 3Monitor your mental health carefully — if depression or anxiety worsens after starting cannabis use, this may be contributing to treatment resistance rather than representing antidepressant failure.
- 4Avoid abrupt changes in cannabis use patterns, as this could affect citalopram levels and cause withdrawal-like symptoms or side effects.
- 5Consider whether cannabis use aligns with your mental health treatment goals and discuss this openly with your provider.
Research Summary
The FDA issued a 2012 safety communication warning about dose-dependent QT prolongation with citalopram, recommending a maximum dose of 40 mg/day. Any pharmacokinetic interaction that increases citalopram levels effectively increases QT risk. CBD's inhibition of CYP2C19 and CYP3A4 has been demonstrated in multiple studies, including the Epidiolex pharmacokinetic data submitted to the FDA. A 2019 meta-analysis in Lancet Psychiatry found that cannabis use was associated with worse depression outcomes and increased incidence of anxiety, though the relationship is bidirectional and complex. A 2020 survey study in the Journal of Affective Disorders found that approximately 25% of patients on antidepressants also used cannabis, highlighting the clinical relevance of this interaction.
Frequently Asked Questions
Can I use cannabis for anxiety while taking Celexa?
This is a complex question. While low-dose CBD may have anxiolytic properties, high-THC cannabis can actually worsen anxiety. Additionally, CBD can increase citalopram levels through metabolic inhibition. Discuss your anxiety management openly with your prescriber rather than self-medicating with cannabis, as they can adjust your treatment plan accordingly.
Will cannabis make my antidepressant less effective?
Possibly. Research suggests that regular cannabis use, especially heavy THC consumption, is associated with worse depression outcomes and may contribute to treatment resistance. This appears to be a pharmacodynamic effect on mood regulation rather than a simple metabolic interaction. If you notice your depression worsening, your cannabis use may be a contributing factor.
Is CBD or THC safer to use with citalopram?
Each carries different concerns. THC is more likely to affect your mental health treatment through mood and anxiety effects, while CBD is more likely to cause a pharmacokinetic interaction by increasing citalopram levels. Neither is entirely free of interaction risk, but low doses of THC with minimal CBD content carry a lower pharmacokinetic concern.
Can I get serotonin syndrome from mixing cannabis and Celexa?
Serotonin syndrome from this combination is very unlikely. While cannabis has some indirect effects on serotonin signaling, it does not significantly increase serotonin levels in the way that other serotonergic drugs do. The risk of serotonin syndrome is primarily relevant when combining SSRIs with other serotonergic medications like MAOIs or tramadol.